SPI1 and diabetes mellitus: Hoxa3-treated mφs showed upregulation of maturation markers F4/80 and CD115 as well a master regulator of mφ development, Spi1/Pu.1, at both transcriptional and protein levels, thus supporting the hypothesis that Hoxa3 rescues diabetes-induced mφ maturation defects.